These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24323138)

  • 1. Community child psychiatric medication experiences measured by an internet-based, prospective parent survey of retail pharmacy customers.
    Hilt R; Wolf C; Koprowicz K; Thomas E; Chandler M; Hao XL; Russell M; Le T; Hooks L; King B
    Community Ment Health J; 2014 Feb; 50(2):172-8. PubMed ID: 24323138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic management of psychiatric and behavioral symptoms in mental retardation.
    Madrid AL; State MW; King BH
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):225-43, x-xi. PubMed ID: 10674198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Child psychopharmacology.
    Simeon JG
    J Am Acad Child Adolesc Psychiatry; 1991 Jul; 30(4):695-6. PubMed ID: 1890111
    [No Abstract]   [Full Text] [Related]  

  • 4. [Psychopharmaceuticals for children and adolescents are better than many seem to think].
    Nissen G
    MMW Fortschr Med; 2005 Dec; 147(48):31; quiz 47-8. PubMed ID: 16389858
    [No Abstract]   [Full Text] [Related]  

  • 5. Psychotropic medication utilization at a group-home residential facility for children and adolescents.
    Handwerk ML; Smith GL; Thompson RW; Spellman DF; Daly DL
    J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):517-25. PubMed ID: 18928416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical issues in child and adolescent psychopharmacology.
    Gadow KD
    J Consult Clin Psychol; 1991 Dec; 59(6):842-52. PubMed ID: 1774369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitudes and experience of youth and their parents with psychiatric medication and relationship to self-reported adherence.
    O'Brien M; Crickard E; Lee J; Holmes C
    Community Ment Health J; 2013 Oct; 49(5):567-75. PubMed ID: 22820929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practice parameter on the use of psychotropic medication in children and adolescents.
    Walkup J;
    J Am Acad Child Adolesc Psychiatry; 2009 Sep; 48(9):961-973. PubMed ID: 19692857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of psychopharmacologic agents in children and adolescents.
    Carlson GA; Ranade L; Qadir A
    Psychiatr Q; 1992; 63(4):391-411. PubMed ID: 1361998
    [No Abstract]   [Full Text] [Related]  

  • 10. Brief report: variables related to parental choice to medicate their autistic children.
    Konstantareas M; Homatidis S; Cesaroni L
    J Autism Dev Disord; 1995 Aug; 25(4):443-52. PubMed ID: 7592254
    [No Abstract]   [Full Text] [Related]  

  • 11. Side effects from use of one or more psychiatric medications in a population-based sample of children and adolescents.
    Hilt RJ; Chaudhari M; Bell JF; Wolf C; Koprowicz K; King BH
    J Child Adolesc Psychopharmacol; 2014 Mar; 24(2):83-9. PubMed ID: 24506790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Internet-Assisted Parent Training Intervention for Disruptive Behavior in 4-Year-Old Children: A Randomized Clinical Trial.
    Sourander A; McGrath PJ; Ristkari T; Cunningham C; Huttunen J; Lingley-Pottie P; Hinkka-Yli-Salomäki S; Kinnunen M; Vuorio J; Sinokki A; Fossum S; Unruh A
    JAMA Psychiatry; 2016 Apr; 73(4):378-87. PubMed ID: 26913614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attitudes of college students toward mental illness stigma and the misuse of psychiatric medications.
    Stone AM; Merlo LJ
    J Clin Psychiatry; 2011 Feb; 72(2):134-9. PubMed ID: 21208582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-Year Follow-Up of Internet and Telephone Assisted Parent Training for Disruptive Behavior at Age 4.
    Sourander A; McGrath PJ; Ristkari T; Cunningham C; Huttunen J; Hinkka-Yli-Salomäki S; Kurki M; Lingley-Pottie P
    J Am Acad Child Adolesc Psychiatry; 2018 Sep; 57(9):658-668.e1. PubMed ID: 30196869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Little recognition of mental problems in children by parents and family physicians].
    Foets M; Cuperus J; Spreeuwenberg P; Verhaak P; van Engeland H
    Ned Tijdschr Geneeskd; 1996 Sep; 140(38):1907-12. PubMed ID: 8927168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. World wide use of psychotropic drugs in child and adolescent psychiatric disorders.
    Simeon JG; Wiggins DM; Williams E
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 May; 19(3):455-65. PubMed ID: 7624496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical perspectives: combined pharmacotherapy.
    Weintrob A
    J Am Acad Child Adolesc Psychiatry; 1995 Dec; 34(12):1558. PubMed ID: 8543525
    [No Abstract]   [Full Text] [Related]  

  • 18. Talking about psychiatric medications: a parent-to-parent perspective (for children and youth) part I.
    Cooper S; Rimm ML; Arensdorf AM
    Hawaii Med J; 2007 Oct; 66(10):260, 262-4. PubMed ID: 18065122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Convergent validity of K-SADS-PL by comparison with CBCL in a Portuguese speaking outpatient population.
    Brasil HH; Bordin IA
    BMC Psychiatry; 2010 Oct; 10():83. PubMed ID: 20955616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parent and child contributions to diagnosis of mental disorder: are both informants always necessary?
    Jensen PS; Rubio-Stipec M; Canino G; Bird HR; Dulcan MK; Schwab-Stone ME; Lahey BB
    J Am Acad Child Adolesc Psychiatry; 1999 Dec; 38(12):1569-79. PubMed ID: 10596258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.